RxDoctor Payments Data

Bailey Hansen, MD

Internal Medicine · Tupelo, MSNPI 1912431842

Payments from drug & device makers

$833in general payments, 2019–2025

Across 46 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$257
  • United Therapeutics Corporation$56
  • Boehringer Ingelheim$46
  • Otsuka America Pharmaceutical, Inc.$44
  • Averitas Pharma Inc.$41
  • AbbVie$40
  • plus $349 from 15 others

What the payments were for

  • Food & beverage$833100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$833 in reported general payments places this provider in the 60th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$85,835
Medicare patients
173
Services billed
1,957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide30$48,150
EliquisApixaban27$38,182
JanuviaSitagliptin Phosphate27$24,071
TrulicityDulaglutide14$18,345
LinzessLinaclotide15$10,487
JardianceEmpagliflozin11$10,223
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,720
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$5,824
Synjardy XrEmpagliflozin/Metformin Hcl13$4,971
Gabapentin191$3,223
Pantoprazole Sodium116$2,464
Albuterol Sulfate HfaAlbuterol Sulfate72$1,814
Duloxetine Hcl61$1,593
Pregabalin54$1,572
Methocarbamol49$1,336

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$22$48,15030 claims
PfizerEliquis$30$38,18227 claims
Lilly USA, LLCTrulicity$257$18,34514 claims
Boehringer IngelheimJardiance, Synjardy Xr$46$15,19424 claims
AbbVieLinzess$40$10,48715 claims
GSKTrelegy Ellipta$13$9,72015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →